An observational study in Eisenmenger's Syndrome, sponsored by Gachon University Gil Medical Center. Completed. Per ClinicalTrials.gov, last updated 2011-01-26.
Sponsored by Gachon University Gil Medical Center · Observational
Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.
23 studies on the registry are indexed under Eisenmenger Complex; 5 are open to participants now.
Browse Eisenmenger Complex studies →Gachon University Gil Medical Center is the lead sponsor of 90 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
12 patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization
Exclusion Criteria:
No study locations are listed for this record.
The record gives a start of Sep 2007 and a completion of May 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gachon University Gil Medical Center